Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award NEW YORK, NY. March 31, 2021. Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with glucocorticoids (steroids) effective at lower doses, lessening harmful side effects. In a study […] READ MORE
March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus erythematosus (SLE). This study suggests that itolizumab, a monoclonal antibody selectively targeting the CD6-ALCAM pathway, was safe and well tolerated among people with SLE. [Source: Equillium, Inc. Press Release 3.30.21] The EQUALISE study is evaluating […] READ MORE
March 29, 2021 Patients with lupus are more likely to have metabolic syndrome and insulin resistance – both factors linked to heart disease – if they have lower vitamin D levels, a new study reveals. Researchers believe that boosting vitamin D levels may improve control of these cardiovascular risk factors, as well as improving long-term […] READ MORE
NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Jacques Banchereau, PhD and Ignacio Sanz, MD. Both projects funded by this grant are investigating different mechanisms altered in lupus patients that induce an autoimmune response. Their findings […] READ MORE
March 19, 2021 Ten new applications for promising scientific studies were just recommended for funding by the Lupus Research Program (LRP) within the Department of Defense! The dedicated Lupus Research Program was first established in 2017 under the Congressionally Directed Medical Research Programs operated by the Army Medical Research and Materiel Command in Ft. Detrick, […] READ MORE
March 17, 2021 People with systemic lupus erythematosus (SLE) are at risk for cardiovascular diseases, and those with lupus nephritis are at greater risk, according to the findings of a new analysis of 20 clinical studies. Results showed that people with SLE are twice as likely to develop cardiovascular disease as healthy people. Their risk […] READ MORE
March 10, 2021 It’s no coincidence that March is designated as both National Autoimmune Diseases Awareness and Women’s History Months. That recognition is earned every day by the millions of courageous, determined women who fight lupus and other autoimmune diseases. Women are at far greater risk for most autoimmune diseases[i] and most of those the […] READ MORE
Updated March 11, 2022 Neuropsychiatric lupus affects 80-90% of people with lupus. In a video series hosted by the Young Leaders Board of the Lupus Research Alliance, Dr. Meggan Mackay explains How to know if you have neuropsychiatric lupus and offers ways to improve cognitive health. Dr. Mackay also describes a clinical trial she is […] READ MORE
March 1, 2021 Americans gained a third weapon against COVID-19 this weekend with the availability of a third vaccine. On February 27, 2021, the U.S. Food and Drug Administration granted Emergency Use Authorization to the new vaccine from Janssen Pharmaceutical Companies of Johnson & Johnson to prevent COVID-19 in adults age 18 and older. The […] READ MORE
What’s New in Lupus Nephritis? A Research & Treatment Update A Learn from Lupus Webcast Lupus nephritis is a common and dangerous complication of lupus marked by inflammation that can lead to damage and possible failure of the kidney. While up to half of people with lupus develop lupus nephritis, a new survey by the Lupus […] READ MORE
February 25, 2021 Dr. Ashira Blazer is literally a rising star. This year, she won the 40 Under 40 Leaders in Minority Health Award sponsored by the National Minority Quality Forum, an organization with which the Lupus Research Alliance works closely. But what makes her a winner? And why is the LRA celebrating her during […] READ MORE
Important news for people with lupus as COVID-19 vaccines are on everyone’s minds. The foremost authority in rheumatologic diseases, the American College of Rheumatology (ACR) recently issued the COVID-19 Vaccine Clinical Guidance. Developed by a panel of rheumatologists, specialists in infectious disease and public health experts, the Guidance aims to help healthcare providers make decisions with their […] READ MORE
